FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approves Slate Run Pharmaceuticals' original application for CYCLOPHOSPHAMIDE FOR INJECTION, expanding the market for a generic cyclophosphamide injectable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Breast Cancer
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE FOR INJECTION (cyclophosphamide)

Snippet

ORIG AP for CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE FOR INJECTION)